290 likes | 413 Vues
This presentation by Dr. Paul J. Seligman at the PATHS Annual Meeting discusses the critical role of stakeholder involvement in the realm of drug safety. With over 10,000 drug products marketed in the U.S., including branded, generic, and over-the-counter options, understanding safety-related information is vital. The presentation highlights challenges related to health literacy, the diversity of information sources, and the need for clear communication. It also emphasizes the importance of partnerships in reaching healthcare professionals and patients to ensure timely, accessible, and actionable drug safety information.
E N D
1. 1 Best Practices in Stakeholder Involvement Paul J. Seligman, M.D., M.P.H.
Associate Director, Safety Policy & Communication
Center for Drug Evaluation and Research/FDA
PATHS Annual Meeting
September 2008
2. 2 Challenges Drug Products 10,000+ products marketed in US
Branded
Generic
Over-the-counter
For wide variety of uses and conditions
Life saving
Preventative
Symptomatic
Over 900 safety-related label changes/year
Warnings, precautions, adverse events
3. 3 Challenges Drug Products Everyone uses drugs
Language
Health literacy
Information everywhere
Professional label
Consumer Medication Information
Patient Package Inserts
Medication Guides
FDA Alerts
4. 4 Reaching the AudienceThe Role of Partners MedWatch
Patient Safety News
Meeting the needs of busy healthcare professionals and their patients
Providing easy and quick access to timely and actionable information
5. 5